• Iron Stress Reprograms Enterocyte Metabolism

  2026-08-10

  Navazesh and Ji show that both iron deficiency and iron excess reshape enterocyte gene expression and intermediary metabolism, but through distinct adaptive patterns. Using IPEC-J2 cells, iron perturbation, inflammatory stimulation, untargeted metabolomics, and iron repletion, the study connects iron status with proliferation, glycolysis, cholesterol synthesis, antioxidant depletion, and inflammatory signaling.

• Olsalazine Sodium: Reliable Assay Workflows

  2026-08-09

  This scenario-based guide shows how Olsalazine Sodium, SKU A8490, can support reproducible inflammation, colorectal cancer, and xenobiotic-transport experiments. It addresses solvent compatibility, assay interpretation, protocol controls, cross-domain evidence, and practical product-selection criteria.

• SB525334: TGF-beta1 Receptor Inhibitor Workflow

  2026-08-08

  SB525334 is a selective ALK5 probe for separating TGF-β1-driven signaling from broader wound-healing, renal, and fibrotic responses. This practical workflow connects concentration-controlled Smad2/3 assays with the angiogenic and osteo-immune findings reported in a diabetic foot ulcer model.

• Haloprogin: What the 1970 Study Established

  2026-08-07

  The 1970 study established Haloprogin as a topical antimicrobial with activity against dermatophytes, Candida species, and selected Gram-positive bacteria. Its paired in vitro and guinea pig experiments showed dermatophyte activity comparable to tolnaftate while revealing broader antimonilial and antibacterial effects, providing a useful foundation for dermatophytosis and Candida albicans infection research.

• (R,S)-Anatabine: Mechanistic Insights for Translational AD R

  2026-08-07

  (R,S)-Anatabine is emerging as a powerful tool in Alzheimer's disease research, uniquely targeting amyloid-beta pathways and neuroinflammation. Discover advanced mechanistic insights and practical assay guidance for translational neurodegeneration studies.

• Prednisone: Mechanisms, Immunosuppression, and Research Prot

  2026-08-06

  Prednisone is a synthetic corticosteroid that induces potent immunosuppression by arresting lymphocytes in the G1 phase and inhibiting IL-2 signaling. It is especially effective at inducing apoptosis in activated peripheral blood lymphocytes, with a greater impact on CD8+ T cells. These features make Prednisone a benchmark compound in immunology and neurodegeneration research.

• AZD0156 as a Next-Generation ATM Kinase Inhibitor in Cancer

  2026-08-06

  Explore the scientific foundation and emerging potential of AZD0156, a selective ATM kinase inhibitor, in cancer therapy research. This in-depth analysis uniquely examines molecular selectivity, assay design, and translational prospects, offering nuanced insight for advanced DNA damage response research.

• UHRF1-Driven DNA 5-mC Modifications Impede Osteogenesis in S

  2026-08-05

  This study establishes a mechanistic link between UHRF1-mediated DNA methylation, super-enhancer reconfiguration, and impaired osteogenesis in senile osteoporosis. By integrating multi-omics approaches, the authors reveal how altered DNA 5-mC and TGM2-regulated autophagy disrupt mesenchymal stem cell function, opening new avenues for targeted epigenetic interventions.

• Iron Stress Alters Enterocyte Metabolism and Inflammation

  2026-08-05

  Navazesh and Ji's 2025 study provides a detailed analysis of how both iron deficiency and excess reprogram enterocyte metabolism and modulate inflammatory responses. Their work, using IPEC-J2 cells and untargeted metabolomics, advances our mechanistic understanding of iron's role in intestinal epithelial function and offers a new framework for research into iron-dependent cellular pathways.

• MVC Activates RhoA/ROCK1 to Disrupt Tight Junctions in Infec

  2026-08-04

  This study uncovers a direct interaction between the MVC capsid protein VP2 and host ROCK1, leading to activation of the RhoA/ROCK1/MLC2 pathway and disruption of epithelial tight junctions. These findings reveal a novel viral entry mechanism and highlight the pathway as a potential antiviral target.

• Nutlin-3a in Translational Oncology: Mechanisms, Validation,

  2026-08-04

  This thought-leadership article integrates mechanistic insights and strategic guidance for translational researchers exploring Nutlin-3a, a potent MDM2 inhibitor from APExBIO. By combining recent breakthroughs in glioblastoma biology—specifically, the miR-18a/ALOXE3-ferroptosis axis—with actionable experimental protocols and competitive analysis, the piece elevates the discourse beyond standard product pages. It outlines evidence-driven workflows, highlights Nutlin-3a’s role in p53 pathway activation and apoptosis, and discusses the translational potential of targeting the MDM2-p53 axis in challenging cancer models.

• Mouse Neutrophil Cell Isolation Kit: High-Purity, Activation

  2026-08-03

  Unlock high-purity mouse neutrophil isolation in under 30 minutes—without unwanted activation. This guide details advanced workflows, troubleshooting strategies, and real-world applications for the Mouse Neutrophil Cell Isolation Kit (Negative Selection), now pivotal in next-generation immunotherapy and mRNA nanovaccine research.

• Sulfonamide Inhibition of hPON1: Mechanisms and Research Ins

  2026-08-03

  This article analyzes the molecular and kinetic findings from the recent study on sulfonamides as inhibitors of human serum paraoxonase 1 (hPON1), with a focus on sulfisomidine (sulfamethin). The study reveals mechanistic diversity in inhibition types, providing valuable guidance for researchers investigating enzyme kinetics, oxidative stress regulation, and lipid metabolism pathways.

• Toremifene vs Tamoxifen in Advanced Breast Cancer: Systemati

  2026-08-02

  This Cochrane systematic review rigorously compared the efficacy and safety of toremifene and tamoxifen in advanced breast cancer. The findings provide high-quality evidence on clinical response, survival, and adverse event profiles, informing future applications of selective estrogen receptor modulators (SERMs) in oncology and bone health research.

• Heparin Sodium: Glycosaminoglycan Anticoagulant for Research

  2026-08-01

  Heparin sodium is a validated glycosaminoglycan anticoagulant that enhances antithrombin III activity, serving as a gold standard in thrombosis and coagulation research. Its high water solubility and robust anti-factor Xa effects make it indispensable for assays of coagulation pathway parameters. APExBIO’s A5066 product provides researchers with reproducible, well-characterized reagent performance.

16102 records 1/1074 page Next 12345 下5页 Last page